Press

Press

Pressfishnyc222024-04-13T17:20:17-04:00

Why Don’t U.S. Guidelines Recommend DPYD Testing Before Chemotherapy?
March 16, 2025

Forbes
Breaking Down the FDA Labeling Update of Xeloda and 5-FU in Cancer Care
February 10, 2025

CURE
The FDA re-issues a Safety Alert addressing the risk of treating patients with DPD deficiency
January 24, 2025

fda.gov
2025 FDA-AACR Workshop: DPD Deficiency And Weighing Potential Harms
January 16, 2025

American Association of Cancer Research
Vimal Scott Kapoor speaks at The National Academies
December 3, 2024

The National Academies
Chemotherapy Could Harm Or Kill You If You Have This Genetic Finding
November 1, 2024

Forbes
How DPD Deficiency Routine Testing Can Save Lives
July 3, 2024

OncoDaily TV
Advocates for Universal DPD/DPYD Testing With Karen Merritt and Dan Hertz, PharmD, PhD
June 28, 2024

Oncology Data Advisor
Design and Implementation of an Opt-Out, End-to-End, Preemptive DPYD Testing Program for Patients Planned for a Systemic Fluoropyrimidine
April 12, 2024

ASCO Publications
Advocates say new labels on some chemotherapy drugs aren’t strong enough
April 1, 2024

WMUK
A quick test could protect against fatal chemo overdose, yet few doctors use it
March 27, 2024

NBC News
FDA Updates Fluorouracil Label With DPD Deficiency Risk Information
March 25, 2024

Precision Medicine Online

Useful links

Why Test
Working with your Oncologist
Treatment Warning Signs
Initiatives
About Us
FAQs
Contact

Subscribe to the newsletter

AUDT is a 501(c)(3) non-profit organization.

© Copyright 2025 | All Rights Reserved | Developed by The Media Council